SCHEMBL9510177

SCHEMBL9510177

CCCCCOc1ccc(-c2ccc(C#Cc3ccc([C@H]4CC[C@H](C)CC4)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.48
HRH3 Q9Y5N1 6/20 0.45
HRH2 P25021 3/20 0.45
HRH1 P35367 3/20 0.45
LMNA P02545 1/20 0.43
RARB P10826 3/20 0.43
CYP2C9 P11712 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MCHR1 Q99705 2/20 0.42
CHRM1 P11229 1/20 0.42
HTR2A P28223 1/20 0.42
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510023 0.97 RAB9A (0.50) RAB9AHRH3HRH2HRH1CYP2C9
SCHEMBL9512268 0.96 RAB9A (0.51) RAB9AHRH3LMNACYP2C9HPGD
SCHEMBL13401992 0.95 RAB9A (0.50) RAB9AHRH3LMNACYP2C9HPGD
SCHEMBL11276971 0.93 RAB9A (0.53) RAB9AHRH3HRH2HRH1LMNA
SCHEMBL9511312 0.93 RAB9A (0.53) RAB9AHRH3LMNACYP2C9CYP3A4
SCHEMBL9509946 0.92 HRH3 (0.44) RAB9AHRH3HRH2HRH1MCHR1
SCHEMBL11283562 0.92 RAB9A (0.52) RAB9AHRH3LMNARARBCYP2C9
SCHEMBL11277730 0.92 RAB9A (0.52) RAB9AHRH3LMNARARBCYP2C9
SCHEMBL11274828 0.92 RAB9A (0.52) RAB9AHRH3LMNARARBCYP2C9
SCHEMBL11287135 0.92 RAB9A (0.52) RAB9AHRH3LMNARARBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed